Theranos founder and CEO Elizabeth Holmes announced the company had developed a blood-testing device that is not yet FDA-approved that she said can run tests from a finger prick, the Wall Street Journal reports. Holmes, who spoke August 1 at the American Association for Clinical Chemistry, did not discuss her company’s recent issues with the federal government.
In July, the Centers for Medicare & Medicaid Services prohibited Holmes from owning or operating a laboratory for two years and revoked the license for a Theranos in Newark, California.
Read the full article below:
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.